Gene:
ABCG8
ATP-binding cassette, sub-family G (WHITE), member 8

PharmGKB contains no prescribing info for this . Contact us to report known genotype-based dosing guidelines, or if you are interested in developing guidelines.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page on the appropriate tab.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

List of all variant annotations for ABCG8

Variant?
(147)
Alternate Names ? Chemicals ? Alleles ?
(+ chr strand)
Function ? Amino Acid?
Translation
No VIP available CA VA
rs11887534 NC_000002.11:g.44066247G>C, NC_000002.12:g.43839108G>C, NG_008883.1:g.4712C>G, NG_008884.1:g.5145G>C, NM_022436.2:c.-429C>G, NM_022437.2:c.55G>C, NP_071882.1:p.Asp19His, XM_005264480.1:c.-429C>G, XM_005264480.2:c.-429C>G, XM_005264481.1:c.-429C>G, XM_005264483.1:c.55G>C, XM_005264483.2:c.55G>C, XM_006712073.2:c.-429C>G, XM_006712074.2:c.-429C>G, XM_011533024.1:c.-429C>G, XM_011533025.1:c.-1172C>G, XM_011533026.1:c.-429C>G, XM_011533027.1:c.-1287C>G, XM_011533029.1:c.76-5399G>C, XM_011533030.1:c.76-5399G>C, XM_011533031.1:c.-153-5399G>C, XP_005264540.1:p.Asp19His, XR_939707.1:n.566-5399G>C, rs17495905
G > C
SNP
D19H
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP 147

Overview

Alternate Names:  gallbladder disease 4; sterolin 2
Alternate Symbols:  GBD4
PharmGKB Accession Id: PA24412

Details

Cytogenetic Location: chr2 : p21 - p21
GP mRNA Boundary: chr2 : 44066103 - 44105947
GP Gene Boundary: chr2 : 44056103 - 44108947
Strand: plus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Statin Pathway, Pharmacodynamics
    Genes involved in mediating statin effects on hepatic cholesterol metabolism and consequent effects on plasma lipoprotein transport.
No related genes are available

Curated Information ?

Evidence Drug
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
atorvastatin

Curated Information ?

Publications related to ABCG8: 9

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The expression profile of ATP-binding cassette transporter genes in breast carcinoma. Pharmacogenomics. 2013. Hlaváč Viktor, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The ABCG8 G574R Variant, Serum Plant Sterol Levels, and Cardiovascular Disease Risk in the Old Order Amish. Arteriosclerosis, thrombosis, and vascular biology. 2012. Horenstein Richard B, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study. The pharmacogenomics journal. 2011. de Keyser C E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Common sequence variants in pharmacodynamic and pharmacokinetic pathway-related genes conferring LDL cholesterol response to statins. Pharmacogenomics. 2010. Chien Kuo-Liong, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Effect of genetic variant (rs11887534) in ABCG8 gene in coronary artery disease and response to atorvastatin therapy. Disease markers. 2010. Srivastava Anshika, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation. PloS one. 2009. Hesselson Stephanie E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nature genetics. 2007. Buch Stephan, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
An association study of 43 SNPs in 16 candidate genes with atorvastatin response. The pharmacogenomics journal. 2005. Thompson J F, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol-lowering response to atorvastatin. Atherosclerosis. 2004. Kajinami Kouji, et al. PubMed

LinkOuts

NCBI Gene:
64241
OMIM:
210250
605460
611465
UCSC Genome Browser:
NM_022437
RefSeq RNA:
NM_022437
RefSeq Protein:
NP_071882
RefSeq DNA:
NG_008884
NT_022184
UniProtKB:
ABCG8_HUMAN (Q9H221)
Ensembl:
ENSG00000143921
GenAtlas:
ABCG8
GeneCard:
ABCG8
MutDB:
ABCG8
ALFRED:
LO022621N
HuGE:
ABCG8
Comparative Toxicogenomics Database:
64241
ModBase:
Q9H221
HumanCyc Gene:
HS07126
HGNC:
13887

Common Searches